We are live on !
Find out more
Summit Partners Portfolio holdings
AUM
$491M
Turnover
0%
1-Year Est. Return
11.09%
This Fund
S&P 500
This Quarter Est. Return
-15.37%
1 Year Est. Return
+11.09%
3 Year Est. Return
+23.17%
5 Year Est. Return
-22.98%
10 Year Est. Return
-29.03%
AUM
$2.9B
AUM Growth
+$976M
(+51%)
Cap. Flow
+$1.74B
Cap. Flow % of AUM
Cap. Flow %
59.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
4
Increased
–
Reduced
1
Closed
–
Avg Time Held
2.3
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESMT
EngageSmart
ESMT
|
+$925M |
| 2 |
a.k.a. Brands
AKA
|
+$692M |
| 3 |
Markforged Holding
MKFG
|
+$129M |
| 4 |
Sharecare
SHCR
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lifestance Health
LFST
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 55.28% |
| 2 | Healthcare | 23.27% |
| 3 | Consumer Discretionary | 21.45% |
Similar funds
Summit Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Summit Partners held 9 positions worth $2.9B, up 51% from $1.92B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Summit Partners deployed $1.74B of net new capital in Q3 2021, opening 4 new positions. Its largest new stake was EngageSmart: 26,926,752 shares worth $917M.
By sector, the portfolio is most concentrated in Technology at 55% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lifestance Health, an estimated $22M trimmed.
- Summit Partners's largest Q3 2021 buy was EngageSmart: 26,926,752 shares worth $917M.
- Summit Partners's biggest Q3 2021 reduction was Lifestance Health, cutting an estimated $22M.
- Summit Partners's ten largest holdings make up 100% of its $2.9B portfolio in Q3 2021.
- Summit Partners opened 4 new positions and closed 0 in Q3 2021.
- Summit Partners's portfolio value rose 51% quarter-over-quarter to $2.9B.
Based on Summit Partners's 13F filing for Q3 2021, filed 12 Nov 2021.